RxDoctor Payments DataLook up a doctor →

Carlton Miller

Rheumatology · Colonial Heights, VANPI 1295793727

Payments from drug & device makers

$12,011in general payments, 2019–2025

Across 549 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • Johnson & Johnson$2K
  • AbbVie$1K
  • Pfizer$993
  • Mallinckrodt Hospital Products Inc.$672
  • UCB, Inc.$659
  • plus $4K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)136$2,864
Johnson & Johnson52$1,774
AbbVie42$1,026
Pfizer66$993
Mallinckrodt Hospital Products Inc.27$672
UCB, Inc.33$659
Novartis20$427
E.r. Squibb & Sons, L.L.C.18$357
Lilly USA, LLC19$331
AstraZeneca(2 entities)16$322
Radius Health, Inc.13$289
GSK16$275
ANI Pharmaceuticals, Inc.8$191
Bioventus LLC7$179
Bristol Myers Squibb4$170
Boehringer Ingelheim9$165
Aurinia Pharma U.S., Inc.8$162
Organon7$147
Actelion Pharmaceuticals US, Inc.6$126
Sandoz5$119
Sanofi5$98
Janssen Scientific Affairs, LLC1$95
Genentech USA, Inc.5$70
Fidia Pharma USA Inc.3$67
Octapharma USA, Inc.2$46
Regeneron Healthcare Solutions, Inc.2$43
Biocon Biologics Inc2$37
Fresenius Kabi USA, LLC2$37
Mylan Institutional Inc.2$35
Pacira Therapeutics, Inc.1$30
Sobi, Inc2$29
Medexus Pharma, Inc.2$28
Invivyd Inc1$26
Ferring Pharmaceuticals Inc.1$24
Kiniksa Pharmaceuticals International, PLC1$22
Tonix Medicines, Inc.1$18
Pharming Healthcare, Inc.1$17
Ultragenyx Pharmaceutical Inc.1$17
Sebela Pharmaceuticals Inc.1$12
Hikma Pharmaceuticals USA1$12

How this compares

$12,011 in reported general payments places this provider in the 75th percentile of 159 rheumatology providers in Virginia.

See all rheumatology providers in Virginia →

Medicare billing

Part B allowed, 2024
$1,180,891
Medicare patients
458
Services billed
72,529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Colonial Heights

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →